Bumetanide and Tasmar drug interactions - a phase IV clinical study of FDA data

Summary:

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Tasmar. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Tasmar?

Tasmar has active ingredients of tolcapone. eHealthMe is studying from 1,275 Tasmar users. Check the latest studies of Tasmar.



On May, 04, 2026

3 people who take Bumetanide and Tasmar together, and have interactions are studied.

Bumetanide and Tasmar drug interactions.

What are the common drug interactions of Bumetanide and Tasmar, by gender? *:

female:

  1. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  2. Constipation
  3. Depression
  4. Headache (pain in head)
  5. Nervousness
  6. Oedema lower limb (fluid collection in tissue of lower leg)
  7. Weakness
  8. Abdominal distension

male:

  1. Cardiac failure congestive
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Bumetanide and Tasmar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  2. Constipation
  3. Depression
  4. Headache (pain in head)
  5. Nervousness
  6. Oedema lower limb (fluid collection in tissue of lower leg)
  7. Weakness
  8. Abdominal distension
  9. Cardiac failure congestive
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Tasmar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bumetanide and Tasmar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tasmar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tasmar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide and tolcapone (the active ingredients of Bumetanide and Tasmar, respectively), and Bumetanide and Tasmar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: